News

PDL believes the move will help boost the potential value of its ulcerative colitis treatment Nuvion and Roche co-developed organ rejection treatment Zenapax, as well as expanding its

E1-INT is a short course combination therapy aimed at stimulating the regeneration of the body’s insulin-producing cells. This type 2 diabetes clinical trial will be conducted in the

The European patent designates 18 countries in Europe and is in addition to similar patents issued to Pozen in the US and Australia. Equivalent patent applications are pending

Both endpoints were met in the first stage of Adventrx’ two-stage design phase II trial using CoFactor to modulate the effect of 5-fluorouracil (5-FU) in patients with metastatic

Following this affirmative Ministry of Health, Labour and Welfare (MHLW) decision, Enbrel (etanercept) will now be co-promoted by both Wyeth and Takeda Pharmaceutical in Japan. “We are pleased

YM BioSciences was advised by its European partner, Oncoscience AG, that a phase II trial in children with brain cancer (glioma) utilizing the EGF receptor monoclonal antibody (h-R3)

This acquisition was financed through Atrium’s working capital, as well as from a new banking credit facility. “The Multichem acquisition allows us to significantly increase our presence on

Tiazac XC is a novel, extended-release formulation of diltiazem hydrochloride that features a new diffusion technology (DiTech) delivery system designed for night-time administration, resulting in improved 24-hour blood

Under the extension, which was permitted under the terms of the existing agreement, established in December 2003, Merck will continue to contribute drug candidates to the collaboration and